Helix and QIAGEN Partner to Develop Companion Diagnostics for Hereditary Diseases
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Company News, Diagnostic Technologies |
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Andy Lundin | Oct 25, 2022 | Infectious Diseases |
Researchers from UVA have been selected to help establish a national pathogen genomics surveillance network.
Read MorePosted by Bryce Lochmann | Jun 17, 2022 | Covid 19, Diagnostic Technologies |
Abbott’s ID NOW™ testing platform has emerged as an alternative to PCR for more rapid molecular detection of SARS-CoV-2 at the point of care with NEAR detection technology.
Read MorePosted by Andy Lundin | Jun 17, 2022 | Company News, Diagnostic Technologies |
Nordic Bioscience is collaborating with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up.
Read MorePosted by Andy Lundin | Apr 19, 2022 | Covid 19 |
A new study found that smartwatch technology can help someone infected with COVID-19 to track the progression of their symptoms.
Read More